23andMe quickly gained notoriety by providing private customers with health and ancestry information directly from their sequenced DNA, then, in 2013, it was stopped from providing health details by the FDA. Now it’s got the green light to resume.
23andMe made a name for itself selling DNA test kits, but today it announced a radical new direction: The company will start mining its huge database of DNA sequences to create new drugs. The science of how they could do that is fascinating—but it raises a lot of futuristic ethical questions too.
Fast Company has a profile on 23andMe, the de facto public face of genetic testing, that's worth a read just for the look at the underpinnings of the science. But there's a moment in there that teases out the gut punch that can come from that knowledge, and that's closely related to how genetic testing in sports might…
Genetic testing has taken off in recent years. Companies like 23andMe and Medcan are finally allowing people to get their DNA tested so that they can better understand their genetic lineage and determine if they're prone to certain diseases. Now all this sounds good in theory — but what if your genetic tests yielded…
Walgreens plans to sell genetic testing kits for the first time in brick and mortar stores, but the FDA thinks this shift from labs/internet to pharmacy may be too much too fast.
At the advice of many medical experts, I'm leaving the following article, in which I'll discuss my personal probabilities of disease based upon my genetics, unsigned.